Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke

Mark McDonald, James C. Grotta(Memorial Hermann), Andrea Elliott(University of Minnesota), Navdeep Sangha(Kaiser Permanente West Los Angeles Medical Center), Evan G. Pivalizza, Ritvij Bowry(The University of Texas Health Science Center at Houston), Amanda Hassler, Jessica Messier(The University of Texas Health Science Center at Houston), Joancy Archeval-Lao, Tiffany Chang(The University of Texas Health Science Center at Houston), Chunyan Cai, Jorge Kawano-Castillo, Stephanie Parker, Jeremy Wetzel, Stuart Fraser(The University of Texas Health Science Center at Houston), Mohammad H. Rahbar(The University of Texas Health Science Center at Houston)
Journal of Thrombosis and Thrombolysis
September 25, 2015
10.1007/s11239-015-1280-9
Cited by 30

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke
|Stroke|2015|657
Houston Paramedic and Emergency Stroke Treatment and Outcomes Study (HoPSTO)
|Stroke|2005|254
Necroptosis, a novel form of caspase‐independent cell death, contributes to neuronal damage in a retinal ischemia‐reperfusion injury model
|Journal of Neuroscience Research|2009|250
Increased Pelvic Vein Thrombi in Cryptogenic Stroke
|Stroke|2003|224